Oragenics Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on May 14, 2004. The company is incorporated in Florida and maintains its principal executive offices in Alachua, Florida.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than financial performance data.
Material Changes
The primary material event reported is the approval of the company's common stock listing application by the American Stock Exchange. The stock will trade under the symbol "ONI."
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) and a Regulation FD disclosure regarding the stock listing approval. No specific financial guidance, management commentary on future performance, or discussion of risks and contingencies is included in this text.
Key Facts for Investors to Verify
- Confirmation that Oragenics Inc. common stock is now listed on the American Stock Exchange under the symbol "ONI."
- Verification of the trading start date for the new listing.
- Review of the full press release (Exhibit 99.1) for additional context on the listing approval.